Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

2009958 citationsJournal Articlebronze Open Access

Authors

David L. Horn · Thomas Jefferson University

Dionysios Neofytos · Thomas Jefferson University Hospital

Elias Anaissie · University of Arkansas for Medical Sciences

Jay A. Fishman · Massachusetts General Hospital

William J. Steinbach · Duke University

Ali J. Olyaei · Oregon Health & Science University

Kieren A. Marr

Abstract

The epidemiology and choice of therapy for candidemia are rapidly changing. Additional study is warranted to differentiate host factors and differences in virulence among Candida species and to determine the best therapeutic regimen.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Neutropenia and Cancer Infections

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 48, Issue 12, pp. 1695-1703

DOI: 10.1086/599039

Field-Weighted Citation Impact: 35.29